February 2019: Television Advertisement for Solpadeine Max (Paracetamol and Codeine) by Omega Pharma Limited
Updated 11 June 2019
© Crown copyright 2019
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/advertising-investigations-february-2019/february-2019-television-advertisement-for-solpadeine-max-paracetamol-and-codeine-by-omega-pharma-limited
A healthcare professional and a member of the public complained about an advertisement for Solpadeine Max which was broadcast on television in June 2018 on UK Channel 4. The complainants alleged that there was no warning about the potential dangers for addiction and that the product should not be taken for more than three days.
MHRA did not uphold the complaint. The advertisement seen by MHRA contained the wording ‘Contains Codeine. Can cause addiction. Use for 3 days only. Always read the label.’ in accordance with guidance agreed with the Proprietary Association of Great Britain.